Metraipolis › archive › dc_bae4dfc48d4b

DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed EGFR-Mutant Lung Cancer and Two Cases of Tarlatamab Therapy — Europe PMC PMID:41256964

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41256964
DOI
10.1016/j.jtocrr.2025.100913
License (as archived)
solo-consultazione
Archived
2026-11-09T16:46:09.928Z
SHA-256 of the archived text
026ce6ab3be6694d2d711284ccff6220e7983c774d4d2af101732d99c84a545c
Stable URL of this page
https://metraipolis.com/documento/dc_bae4dfc48d4b

How to cite

DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed EGFR-Mutant Lung Cancer and Two Cases of Tarlatamab Therapy — Europe PMC PMID:41256964 — Europe PMC (en), https://europepmc.org/article/MED/41256964 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bae4dfc48d4b (Metraipolis archive dc_bae4dfc48d4b, sha256 026ce6ab3be6694d2d711284ccff6220e7983c774d4d2af101732d99c84a545c)
BibTeX
@misc{dcbae4dfc48d4b,
  title = {DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed EGFR-Mutant Lung Cancer and Two Cases of Tarlatamab Therapy — Europe PMC PMID:41256964},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41256964},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bae4dfc48d4b; sha256 026ce6ab3be6694d2d711284ccff6220e7983c774d4d2af101732d99c84a545c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41256964. Agents can read the archived copy with the MCP tool read_document.